| Old Articles: <Older 33181-33190 Newer> |
|---|
 |
The Motley Fool
November 25, 2008
David Lee Smith |
Has BHP Billiton Cut Bait for Good? Following a protracted effort, BHP Billiton has ended its pursuit of Rio Tinto.   |
The Motley Fool
November 25, 2008
Dave Mock |
3 Reasons to Buy Yahoo! Today There are many, but here are the three main reasons Yahoo! is worth buying now. |
The Motley Fool
November 25, 2008
Brian Orelli |
Schering's Peacock Imitation The company lays out its pipeline for investors to see; there are some potential blockbusters waiting there. |
The Motley Fool
November 25, 2008
Rich Duprey |
Executives Gorge; Shareholders Get Bellyache The willingness of boards to hand out gross-up payments is symptomatic of a "no-holds-barred" atmosphere permeating executive suites. |
The Motley Fool
November 25, 2008
Alyce Lomax |
Turnaround a Tall Order for Talbots Betting on Talbots' turnaround remains a speculative and risky move. |
The Motley Fool
November 25, 2008
Rick Aristotle Munarriz |
An Unlit Holiday Kindle Just as Amazon ran out of its proprietary e-book readers shortly after last November's debut, the leading online retailer is once again sold out. |
The Motley Fool
November 25, 2008
David Lee Smith |
Constructing a Case for a Beaten-Down Group Washington's push for infrastructure work could benefit the big builders. |
The Motley Fool
November 25, 2008
Rich Smith |
Lockheed's Lightning Storms Norway Mega-defense contractor Lockheed Martin learns that it has won the coveted contract to replace Norway's aging fleet of F-16 fighter jets, beating out Sweden's Gripen International for the honor. |
The Motley Fool
November 25, 2008
Dan Caplinger |
Will Microsoft Save Christmas? Through Live Search and eBay, the company's giving money away. |
The Motley Fool
November 25, 2008
Brian Orelli |
Genentech Exhales The biotech had everything to lose and almost nothing to gain with its recent clinical trial. |
| <Older 33181-33190 Newer> Return to current articles. |
